Greenbrook TMS Past Earnings Performance
Past criteria checks 0/6
Greenbrook TMS's earnings have been declining at an average annual rate of -33%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 18.4% per year.
Key information
-33.0%
Earnings growth rate
-6.6%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 18.4% |
| Return on equity | n/a |
| Net Margin | -69.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Greenbrook TMS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 75 | -52 | 32 | 0 |
| 31 Mar 24 | 72 | -53 | 32 | 0 |
| 31 Dec 23 | 74 | -49 | 31 | 0 |
| 30 Sep 23 | 74 | -92 | 30 | 0 |
| 30 Jun 23 | 77 | -96 | 37 | 0 |
| 31 Mar 23 | 73 | -90 | 36 | 0 |
| 31 Dec 22 | 67 | -88 | 36 | 0 |
| 30 Sep 22 | 62 | -38 | 35 | 0 |
| 30 Jun 22 | 54 | -26 | 28 | 0 |
| 31 Mar 22 | 54 | -25 | 27 | 0 |
| 31 Dec 21 | 52 | -25 | 27 | 0 |
| 30 Sep 21 | 48 | -26 | 27 | 0 |
| 30 Jun 21 | 47 | -30 | 26 | 0 |
| 31 Mar 21 | 43 | -33 | 24 | 0 |
| 31 Dec 20 | 43 | -30 | 22 | 0 |
| 30 Sep 20 | 46 | -28 | 21 | 0 |
| 30 Jun 20 | 42 | -24 | 20 | 0 |
| 31 Mar 20 | 40 | -17 | 20 | 0 |
| 31 Dec 19 | 36 | -16 | 21 | 0 |
| 30 Sep 19 | 30 | -10 | 16 | 0 |
| 30 Jun 19 | 27 | -8 | 13 | 0 |
| 31 Mar 19 | 24 | -6 | 11 | 0 |
| 31 Dec 18 | 21 | -5 | 9 | 0 |
| 30 Sep 18 | 18 | -5 | 7 | 0 |
| 30 Jun 18 | 16 | -4 | 7 | 0 |
| 31 Mar 18 | 15 | -3 | 5 | 0 |
| 31 Dec 17 | 14 | -2 | 5 | 0 |
| 31 Dec 16 | 7 | -2 | 3 | 0 |
| 31 Dec 15 | 4 | -2 | 2 | 0 |
Quality Earnings: GBNH.F is currently unprofitable.
Growing Profit Margin: GBNH.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GBNH.F is unprofitable, and losses have increased over the past 5 years at a rate of 33% per year.
Accelerating Growth: Unable to compare GBNH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GBNH.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: GBNH.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.